Global No. 1 tennis participant Novak Djokovic, who used to be deported from Australia over vaccine rules, has invested in a Danish biotech company which is aiming to broaden a clinical remedy to counter Covid-19.
Novak Djokovic used to be deported from Australia over failure to conform to vaccine mandate (Reuters Picture)
HIGHLIGHTSDjokovic made the funding in June 2020, in step with the CEOThe Danish biotech company QuantBioRes is operating on creating a clinical remedy to counter CovidDjokovic used to be deported from Australia after he didn’t conform to vaccine rules
Tennis champion Novak Djokovic has an 80% stake of Danish biotech company QuantBioRes, which is aiming to broaden a clinical remedy to counter COVID-19, the corporate’s leader government advised Reuters on Wednesday.
CEO Ivan Loncarevic, who described himself as an entrepreneur, stated the funding used to be made in June 2020 however declined to mention how a lot it used to be.
QuantBioRes has round 11 researchers running in Denmark, Australia and Slovenia, in step with Loncarevic, who stressed out they had been running on a remedy, now not a vaccine.
The corporate is creating a peptide, which inhibits the coronavirus from infecting the human mobile, expects to release medical trials in Britain this summer time, he added.
A spokesperson for Djokovic didn’t right away reply to a request for remark.
The tennis primary has stoked international debate concerning the rights of people that choose to not get vaccinated after he used to be deported from Australia on Sunday night time, ruling him out of the Australian Open.
Click on right here for IndiaToday.in’s entire protection of the coronavirus pandemic.
